France · Investor

Ipsen

Last cheque observed Feb 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

Series BSeries ASeries CInternetVideoBiotechnology

Cheques on record
0%of best year0cheques in 12 months, 7 on record
Since the last cheque3539days00hrs00min00sec
Median round$41MRounds led0 of 7Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 83%
Pitch Ipsen

Ipsen highlights

  1. 01

    7 rounds on record

  2. 02

    Mostly Series B and Series A: 67% of its rounds

  3. 03

    Sole investor in 1 rounds, median $45M

  4. 04

    1 exits from the portfolio

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Sectors
InternetVideoBiotechnology
Based in
Boulogne Billancourt, France
Cold pitches
Not stated

The record

Every round we can evidence, newest first7 appearances

  1. 2017

    1 round

  2. Feb
    RhythmUS · FinSMEs$41MWith 6 others
  3. 2015

    1 round

  4. Aug
    Rhythm PharmaceuticalsSeries A · US$40MWith 7 others
  5. 2014

    1 round

  6. Feb
    Thesan PharmaceuticalsSeries B$49MWith 6 others
  7. 2012

    2 rounds

  8. Nov
    Rhythm PharmaceuticalsSeries B · US · pehub.com$8.0MWith 4 others
  9. Jun
    Rhythm PharmaceuticalsSeries B · US · rhythmtx.com$25MWith 3 others
  10. 2011

    1 round

  11. Dec
    BiomeasureVenture · US · masshightech.com$45MSole investor
  12. 2010

    1 round

  13. Nov
    SyntaxinSeries C · GB · fiercebiotech.com$29MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

SyntaxinBought by Ipsen$206MJul 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Syntaxin$206MJul 2013
Octagen$37MJun 2008
Tercica$480MJun 2008

Who they invest alongside

The investors most often in the same rounds as Ipsen. A count of rooms they were both in, not a relationship either has claimed.

New Enterprise AssociatesVC firm4rounds togetherThird Rock VenturesVC firm4rounds togetherMPM CapitalPrivate equity3rounds togetherPfizerCorporate VC3rounds togetherAbingworthVC firm2rounds togetherDeerfieldVC firm2rounds togetherJohnson & Johnson Development Corporation (JJDC)VC firm2rounds togetherLundbeckfond VenturesVC firm2rounds togetherOrbiMedPrivate equity2rounds together

Quick answers about Ipsen

What does Ipsen invest in?

Ipsen invests most often at Series B and Series A (67% of the rounds on record), in sectors such as Internet, Video and Biotechnology.

How active is Ipsen?

7 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2017.

What has Ipsen invested in recently?

Its most recent investments on record: Rhythm (Undisclosed round, Feb 2017).

How big are Ipsen's cheques?

The median round it joins is $41M.

Does Ipsen lead rounds?

Rarely, if at all: none of its 7 investments on record names it as the lead.

Where does Ipsen invest?

Most of the companies it backs are in the United States (83%) and the United Kingdom (17%).

Is Ipsen investing now?

No investments in the last 12 months; the latest was in Feb 2017.

Who does Ipsen invest alongside?

Most often New Enterprise Associates (4 rounds together), Third Rock Ventures (4 rounds together) and MPM Capital (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it